procarboxypeptidase

procarboxypeptidase

 [pro″kahr-bok″se-pep´tĭ-dās]
the inactive precursor of carboxypeptidase, which is converted to the active enzyme by the action of trypsin.

pro·car·box·y·pep·ti·dase

(prō'kar-bok'sē-pep'ti-dās),
Inactive precursor of a carboxypeptidase.

pro·car·box·y·pep·ti·dase

(prō'kahr-boks'ē-pep'ti-dās)
Inactive precursor of a carboxypeptidase.
Mentioned in ?
References in periodicals archive ?
(24.)Bouma BN, Meyers JC Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U) J Thromb Haemost 2003, 1 1566-74.
Enghild, "Human procarboxypeptidase U, or thrombin-activable fibrinolysis inhibitor, is a substrate for transglutaminases: evidence for transglutaminase-catalyzed cross-linking to fibrin," Journal of Biological Chemistry, vol.
Carboxypeptidase U (CPU, (1) activated thrombin-activable fibrinolysis inhibitor; EC 3.4.17.20) is a recently discovered enzyme present in the circulation as its zymogen, procarboxypeptidase U [proCPU; thrombin-activable fibrinolysis inhibitor (TAFI)].
Procarboxypeptidase R is an acute phase protein in mouse, whereas carboxypeptidase N is not.
TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex.
Proteolytic activation of purified procarboxypeptidase U.
Immunological assay for the determination of procarboxypeptidase U antigen levels in human plasma.
Assay of procarboxypeptidase U, a novel determinant of the fibrinolytic cascade, in human plasma.
Fast kinetic assay for the determination of procarboxypeptidase U (TAFI) in human plasma.
Fast and homogeneous assay for plasma procarboxypeptidase U.
Purification and properties of five different forms of human procarboxypeptidases. Eur J Biochem 1989;179:609-16.